Home / Initiative / Covaxin
Initiative Covaxin
Asked 2 times across 2 UPSC exams, peaking in 2022.
Key insights
- Most tested in CSE — 1 of 2 PYQs
- Most asked in 2022
- Recurs across 1 years (2022–2022)
How it travelled across exams
First appearance in each exam — the same idea, reframed.
CSE 2022 → GEO 2022
How the concept evolved
Rising — more than half its appearances (2 of 2) are since 2016.
Related concepts
Ideas UPSC tests alongside this one — keep exploring.
Sample questions
You've seen the pattern — here are a few of the actual PYQs.
CSE2022
In the context of vaccines manufactured to prevent COVID-19 pandemic, consider the following statements
- The Serum Institute of India produced COVID-19 vaccine named Covishield using mRNA platform
- Sputnik V vaccine is manufactured using vector based platform
- COVAXIN is an inactivated pathogen based vaccine
Which of the statements given above is/are correct?
- A 1 and 2 only
- B 2 and 3 only ✓
- C 1 and 3 only
- D 1, 2 and 3
✓ Correct answer: (B)
Science & Technology › Biotech & Genetics
GEO2022
Covaxin, a COVID-19 vaccine manufactured in India, is
- A a live attenuated virus vaccine
- B an inactivated whole virus vaccine ✓
- C a messenger RNA vaccine
- D a protein subunit vaccine
✓ Correct answer: (B)
Science & Technology › Biology & Health
Study how UPSC repeats — not just the papers
₹199 / 1 year · Founding Member
Full access unlocks the three things no PYQ PDF gives you:
① Cross-exam learning — see the same idea recur across CSE, CAPF, CDS and NDA.
② Topic evolution — how each idea is framed, year by year.
③ Question intelligence — every PYQ + answer, linked to related concepts and similar questions.
e.g. Round Table Conference: CDS 2017 → CSE 2017 → … → CAPF 2024
15 days free, no card required — then ₹199 for 1 year.
Start your 15-day free trial →